<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.iongenomics.bio/p/who-did-tempus-ai-beat-out-to-acquire</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-02T20:18:00+00:00</news:publication_date><news:title>Who Did Tempus AI Beat Out to Acquire Personalis? Newsletter Sept. 2, 2026</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/germanys-heidelberg-epignostix-partners</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-02T19:56:29+00:00</news:publication_date><news:title>Germany’s Heidelberg Epignostix Partners With UK NHS on Brain Tumor Methylation Testing</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/carelon-to-cover-guardants-shield</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T18:59:00+00:00</news:publication_date><news:title>Guardant's Shield Colorectal Cancer Screening Test Gains Coverage From Carelon</news:title></news:news></url></urlset>